IL-33–activated dendritic cells induce an atypical TH2-type response
- 31 May 2009
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 123 (5), 1047-1054
- https://doi.org/10.1016/j.jaci.2009.02.026
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33Blood, 2009
- In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiationProceedings of the National Academy of Sciences of the United States of America, 2008
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- TH17 cells in development: an updated view of their molecular identity and genetic programmingNature Reviews Immunology, 2008
- Allergen-Specific In Vitro Cytokine Production in Adult Patients with Eosinophilic EsophagitisDigestive Diseases and Sciences, 2006
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002
- Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 2000
- Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune ResponsesThe Journal of Experimental Medicine, 1999
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsThe Journal of Experimental Medicine, 1997
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992